3625 results for «509»
3625 results
Management of left main bifurcation restenosis
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to manage and treat left main bifurcation restenosis efficiently, whether it be the main branch, the circumflex, or the diffuse bifurcation restenosis.
Beyond the limit – Left main PCI in high-risk patients and complex anatomy
22 May 2019 – From EuroPCR 2019
Consult this session to learn about the treatment options for patients with complex anatomy not suitable for operative revascularisation, the strategies for lesion preparation in left main coronary artery in stable and ACS patient and for left main coronary artery stenting in high-risk patients.
Crushed, dislodged and compressed: features of complicated stent deployment - Part 1
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about how to manage complicated stent deployment, thanks to compelling clinical cases, such as: the rescue of malformed left main ostium stent, stent entrapment in the left anterior descending artery, and more!
How to optimise coronary intervention therapy with SAPIEN 3
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.
Antithrombotic therapy for AF in bioprosthetic valve
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
Valve selection for patients with longer life
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.
TAVI as cutting edge
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn all about LOTUS Edge's current status, long term outcome in japan, and clinical use thanks to a selection of challenging cases.
Beyond the evolution! Latest image guided therapy for structural heart disease intervention 2.0 era
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about EchoNavigator, an innovative tool for guidance of interventional procedures in structural heart disease, and discover how it may help you achieve a better patient outcome.
Imaging Day - Case-based imaging for the mitral valve
14 Feb 2020 – From PCR Tokyo Valves 2020
Which imaging is most relevant to clinical decision-making and procedural planning? Find out more on the pathophysiology of mitral regurgitation.
Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!
MitraClip case in point in Japanese
16 Feb 2020 – From PCR Tokyo Valves 2020
Find out more on the MitraClip NT System Japan post market surveillance, the MitraClip best practice and challenging functional MR cases...
Abstracts in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of abstracts submitted during PCR Tokyo Valves 2020, such as: impact of beta blockers on patients undergoing TAVR, predictive factors of no symptomatic improvement after TAVI, and more!
Complication cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through a selection of complications cases how to manage transcatheter aortic valve migration, aorto-right ventricular fistula after TAVI, and sudden haemodynamic collapse during TAVI.
Remaining limitation of TAVI
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the remaining limitation of TAVI, such as conduction abnormalities, coronary access, severe aortic valve calcification, thanks to a selection of various interesting cases.
My best and worst cases of vascular access
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn thanks to a selection of challenging transcatheter aortic valve implantation cases how to analyse the access sites required, how to manage difficult access and complications, and discover some new approaches.
TAVI basics Co-Medicals - in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about the roles of co-medicals (before and after procedure), the decision-making and strategies prior to TAVI, and the management of comorbidities post TAVI.
Aortic Valve Thrombosis
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on aortic valve thrombosis to learn how to manage the patients with a bioprosthetic valve at high risk of thrombosis and bleeding, and the key role of imaging (echo and CT) in these situations.
Cases in Japanese - PCI, MR & TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: PCI for coronary ischemia after EvolutR implantation, degenerative mitral regurgitation with large gap, bailout of ventricular septal defect after TAVI, and more!
Shared decision making in low-risk patients with aortic stenosis
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover how the concept of low-risk applies in Asian clinical practice, what is the impact of the TAVI low-risk trials on the management of individual patients, and learn more about the future role of the Heart Team.
Strategies to handle complications during interventions for structural heart disease: my worst nightmare - Part 1
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn all about how to handle and avoid complications during interventions for structural heart disease, such as TAVI valve emboli, intra-aortic balloon occlusion, mitral leaflet tear, and more!
